As we have previously discussed, the SASP has pleiotropic and context-dependent effects that can both promote tumor progression and enhance anti-tumor immunity (Reviewed in [97]); thus, it is plausible that the observed decreased of immunological surveillance in tumors with suppression of CDKN2A is mediated by decreased SASP. The gene discussed is CDKN2A; the disease is neoplasm.